Invention Grant
- Patent Title: Esculentin-2CHa peptide and analogues thereof
-
Application No.: US15115532Application Date: 2015-02-02
-
Publication No.: US10202427B2Publication Date: 2019-02-12
- Inventor: Yasser Abdel-Wahab , Peter Flatt , Opeolu Ojo , J. Michael Conlon
- Applicant: UNIVERSITY OF ULSTER
- Applicant Address: GB Coleraine
- Assignee: UNIVERSITY OF ULSTER
- Current Assignee: UNIVERSITY OF ULSTER
- Current Assignee Address: GB Coleraine
- Agency: Klarquist Sparkman, LLP
- Priority: GB1401673.7 20140131
- International Application: PCT/EP2015/052094 WO 20150202
- International Announcement: WO2015/114148 WO 20150806
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/46
Abstract:
The present invention relates to an esculentin-2CHa peptide and analogs thereof, and the use each thereof in the treatment of diabetes, for example type 2 diabetes; insulin resistance; obesity, and/or hypercholesterolemia. Also disclosed is a pharmaceutical composition comprising peptides and analogs according to the present invention; use of peptides and analogs according to the present invention for the manufacture of a medicament for the treatment of diabetes, insulin resistance, obesity, and/or hypercholesterolemia; and methods of treating diabetes, insulin resistance, obesity, and/or hypercholesterolemia.
Public/Granted literature
- US20170166614A1 ESCULENTIN-2CHA PEPTIDE AND ANALOGUES THEREOF Public/Granted day:2017-06-15
Information query
IPC分类:
